Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 22258 | 388 | 25.2 | 45% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
| 110 | 3 | PSYCHIATRY//SCHIZOPHRENIA//BIPOLAR DISORDER | 71389 |
| 3387 | 2 | DIMEBON//REMOXIPRIDE//LATREPIRDINE | 1644 |
| 22258 | 1 | REMOXIPRIDE//AGONIST ANTAGONIST INTERACTION MODEL//1 2 DIAMINOCYCLOPROPANE | 388 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | REMOXIPRIDE | authKW | 999689 | 9% | 37% | 34 |
| 2 | AGONIST ANTAGONIST INTERACTION MODEL | authKW | 157397 | 1% | 100% | 2 |
| 3 | 1 2 DIAMINOCYCLOPROPANE | authKW | 78699 | 0% | 100% | 1 |
| 4 | 3 D MEP DESCRIPTORS | authKW | 78699 | 0% | 100% | 1 |
| 5 | ABINITIO STO 3G CALCULATIONS | authKW | 78699 | 0% | 100% | 1 |
| 6 | AMINOADAMANTAN DERIVATIVES | authKW | 78699 | 0% | 100% | 1 |
| 7 | BIOANAL ANALYT PHARMACEUT RD | address | 78699 | 0% | 100% | 1 |
| 8 | BRL 25594 | authKW | 78699 | 0% | 100% | 1 |
| 9 | CAS 51832 87 2 | authKW | 78699 | 0% | 100% | 1 |
| 10 | CAS 80125 14 0 | authKW | 78699 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 1572 | 38% | 0% | 147 |
| 2 | Psychiatry | 1425 | 22% | 0% | 87 |
| 3 | Chemistry, Medicinal | 1370 | 18% | 0% | 70 |
| 4 | Crystallography | 567 | 11% | 0% | 42 |
| 5 | Chemistry, Multidisciplinary | 141 | 15% | 0% | 58 |
| 6 | Neurosciences | 85 | 11% | 0% | 43 |
| 7 | Toxicology | 41 | 4% | 0% | 15 |
| 8 | Chemistry, Analytical | 27 | 5% | 0% | 20 |
| 9 | Biochemical Research Methods | 24 | 4% | 0% | 14 |
| 10 | Chemistry, Organic | 19 | 5% | 0% | 19 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BIOANAL ANALYT PHARMACEUT RD | 78699 | 0% | 100% | 1 |
| 2 | CENT S 955 KOIWAI YOSHITOMI CHO | 78699 | 0% | 100% | 1 |
| 3 | PHARMACOMETR BIOMETR | 78699 | 0% | 100% | 1 |
| 4 | URA 1848 | 78699 | 0% | 100% | 1 |
| 5 | COORDINAT RADIOCHEM | 39348 | 0% | 50% | 1 |
| 6 | LEIDEN AMSTERDAM DRUG PHARMACOL | 39348 | 0% | 50% | 1 |
| 7 | CERCETARE DEZVOLTARE CHIM FARMACEUT | 19673 | 0% | 25% | 1 |
| 8 | BEHAV BIOCHEM PHARMACOL | 15738 | 0% | 20% | 1 |
| 9 | EXPLORATORY 1 | 15738 | 0% | 20% | 1 |
| 10 | CENT CHIM ORGAN CD NENITESCU | 11241 | 0% | 14% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ACTA PSYCHIATRICA SCANDINAVICA | 15950 | 9% | 1% | 35 |
| 2 | ACTA PHARMACEUTICA NORDICA | 6690 | 1% | 2% | 4 |
| 3 | JOURNAL OF MEDICINAL CHEMISTRY | 5001 | 10% | 0% | 37 |
| 4 | BULLETIN DES SOCIETES CHIMIQUES BELGES | 3524 | 3% | 0% | 10 |
| 5 | ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY | 2476 | 1% | 1% | 4 |
| 6 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2145 | 4% | 0% | 16 |
| 7 | JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION | 2000 | 1% | 1% | 4 |
| 8 | JOURNAL OF CRYSTALLOGRAPHIC AND SPECTROSCOPIC RESEARCH | 1961 | 1% | 1% | 5 |
| 9 | ACTA PHARMACEUTICA SUECICA | 1929 | 1% | 1% | 3 |
| 10 | PSYCHOPHARMACOLOGY | 1863 | 4% | 0% | 17 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | REMOXIPRIDE | 999689 | 9% | 37% | 34 | Search REMOXIPRIDE | Search REMOXIPRIDE |
| 2 | AGONIST ANTAGONIST INTERACTION MODEL | 157397 | 1% | 100% | 2 | Search AGONIST+ANTAGONIST+INTERACTION+MODEL | Search AGONIST+ANTAGONIST+INTERACTION+MODEL |
| 3 | 1 2 DIAMINOCYCLOPROPANE | 78699 | 0% | 100% | 1 | Search 1+2+DIAMINOCYCLOPROPANE | Search 1+2+DIAMINOCYCLOPROPANE |
| 4 | 3 D MEP DESCRIPTORS | 78699 | 0% | 100% | 1 | Search 3+D+MEP+DESCRIPTORS | Search 3+D+MEP+DESCRIPTORS |
| 5 | ABINITIO STO 3G CALCULATIONS | 78699 | 0% | 100% | 1 | Search ABINITIO+STO+3G+CALCULATIONS | Search ABINITIO+STO+3G+CALCULATIONS |
| 6 | AMINOADAMANTAN DERIVATIVES | 78699 | 0% | 100% | 1 | Search AMINOADAMANTAN+DERIVATIVES | Search AMINOADAMANTAN+DERIVATIVES |
| 7 | BRL 25594 | 78699 | 0% | 100% | 1 | Search BRL+25594 | Search BRL+25594 |
| 8 | CAS 51832 87 2 | 78699 | 0% | 100% | 1 | Search CAS+51832+87+2 | Search CAS+51832+87+2 |
| 9 | CAS 80125 14 0 | 78699 | 0% | 100% | 1 | Search CAS+80125+14+0 | Search CAS+80125+14+0 |
| 10 | COPLANAR EFFECT | 78699 | 0% | 100% | 1 | Search COPLANAR+EFFECT | Search COPLANAR+EFFECT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | WADWORTH, AN , HEEL, RC , (1990) REMOXIPRIDE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SCHIZOPHRENIA.DRUGS. VOL. 40. ISSUE 6. P. 863-879 | 42 | 84% | 48 |
| 2 | NADAL, R , (2001) PHARMACOLOGY OF THE ATYPICAL ANTIPSYCHOTIC REMOXIPRIDE, A DOPAMINE D-2 RECEPTOR ANTAGONIST.CNS DRUG REVIEWS. VOL. 7. ISSUE 3. P. 265-282 | 43 | 37% | 15 |
| 3 | STENSLAND, B , CSOREGH, I , HOGBERG, T , (1995) CONFORMATION OF THE 2 POTENTIAL ANTIPSYCHOTIC AGENTS (-)-(S)-3-BROMO-5,6-DIMETHOXY-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]BENZAMIDE, FLB-457, AND ITS 2-HYDROXY ANALOG, FLB-463.ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE. VOL. 51. ISSUE . P. 847-856 | 23 | 72% | 1 |
| 4 | MOVINOSSWALD, G , HAMMARLUNDUDENAES, M , VONBAHR, C , ENEROTH, P , WALTONBOWEN, K , (1995) INFLUENCE OF THE DOSING INTERVAL ON PROLACTIN-RELEASE AFTER REMOXIPRIDE.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 39. ISSUE 5. P. 503-510 | 19 | 68% | 5 |
| 5 | KEKS, N , MCGRATH, J , LAMBERT, T , CATTS, S , VADDADI, K , BURROWS, G , VARGHESE, F , GEORGE, T , HUSTIG, H , BURNETT, P , ET AL (1994) THE AUSTRALIAN MULTICENTER DOUBLE-BLIND COMPARATIVE-STUDY OF REMOXIPRIDE AND THIORIDAZINE IN SCHIZOPHRENIA.ACTA PSYCHIATRICA SCANDINAVICA. VOL. 90. ISSUE 5. P. 358-365 | 15 | 79% | 20 |
| 6 | STENSLAND, B , HOGBERG, T , RAMSBY, S , (1987) STRUCTURE OF REMOXIPRIDE, A NEW ANTIPSYCHOTIC AGENT - COMPARISON OF BASE AND HYDROCHLORIDE FORMS.ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS. VOL. 43. ISSUE . P. 2393-2398 | 18 | 90% | 3 |
| 7 | LEWANDER, T , WESTERBERGH, SE , MORRISON, D , (1990) CLINICAL PROFILE OF REMOXIPRIDE - A COMBINED ANALYSIS OF A COMPARATIVE DOUBLE-BLIND MULTICENTER TRIAL PROGRAM.ACTA PSYCHIATRICA SCANDINAVICA. VOL. 82. ISSUE . P. 92-98 | 12 | 92% | 115 |
| 8 | PAJONK, FG , HOLZBACH, R , NABER, D , (2000) EVALUATION OF EFFICACY OF NEUROLEPTICS IN OPEN VERSUS DOUBLE-BLIND TRIALS: OBJECTIVE.FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE. VOL. 68. ISSUE 7. P. 313 -320 | 17 | 50% | 4 |
| 9 | AHLENIUS, S , ERICSON, E , HILLEGAART, V , NILSSON, LB , SALMI, P , WIJKSTROM, A , (1997) IN VIVO EFFECTS OF REMOXIPRIDE AND AROMATIC RING METABOLITES IN THE RAT.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. VOL. 283. ISSUE 3. P. 1356 -1366 | 20 | 47% | 11 |
| 10 | OGREN, SO , LUNDSTROM, J , NILSSON, LB , (1993) CONCENTRATIONS OF REMOXIPRIDE AND ITS PHENOLIC METABOLITES IN RAT-BRAIN AND PLASMA - RELATIONSHIP TO EXTRAPYRAMIDAL SIDE-EFFECTS AND ATYPICAL ANTIPSYCHOTIC PROFILE.JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION. VOL. 94. ISSUE 3. P. 199-216 | 13 | 81% | 8 |
Classes with closest relation at Level 1 |